SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-010709
Filing Date
2021-03-04
Accepted
2021-03-04 06:55:49
Documents
100
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K syrs-10k_20201231.htm   iXBRL 10-K 4444861
2 EX-4.1 syrs-ex41_226.htm EX-4.1 26513
3 EX-23.1 syrs-ex231_227.htm EX-23.1 7839
4 EX-31.1 syrs-ex311_6.htm EX-31.1 17536
5 EX-31.2 syrs-ex312_10.htm EX-31.2 17510
6 EX-32.1 syrs-ex321_9.htm EX-32.1 7660
7 EX-32.2 syrs-ex322_11.htm EX-32.2 7834
  Complete submission text file 0001564590-21-010709.txt   14753753

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA syrs-20201231.xsd EX-101.SCH 86552
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syrs-20201231_cal.xml EX-101.CAL 80482
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syrs-20201231_def.xml EX-101.DEF 309939
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE syrs-20201231_lab.xml EX-101.LAB 646784
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syrs-20201231_pre.xml EX-101.PRE 556973
13 EXTRACTED XBRL INSTANCE DOCUMENT syrs-10k_20201231_htm.xml XML 2822815
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37813 | Film No.: 21712525
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences